Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

Satici C., Cengel F., Gurkan O., Demirkol M. A., Altunok E. S., Esatoglu S. N.

CLINICAL IMAGING, cilt.75, ss.119-124, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.clinimag.2021.01.028
  • Dergi Adı: CLINICAL IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Biotechnology Research Abstracts, Compendex, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.119-124
  • Anahtar Kelimeler: Mediastinal lymphadenopathy, Radiological findings, COVID-19, Mortality, DISEASE 2019 COVID-19, PROGRESSION
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Purpose: There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in a large group of patients with COVID-19.